Rupintrivir - Experimental Treatment for the Common Cold
Key Data:
Drug (brand / generic)
Rupintrivir (AG7088)
Company/licensee
Agouron Pharmaceuticals (Pfizer subsidiary)
Therapy class
Anti-viral agent
Product description
Protease inhibitor
Current indication
Treatment of colds due to rhinovirus infection
Market sector
Anti-infectives
Development status
PhaseII / III
